Histamine receptor antagonists, proton pump inhibitors and their combination in the treatment of gastro-oesophageal reflux disease-Reference-Cited by-同舟云学术

Histamine receptor antagonists, proton pump inhibitors and their combination in the treatment of gastro-oesophageal reflux disease

Published:2001-06 Issue:3 Volume:15 Page:371-384
ISSN:1521-6918
Container-title:Best Practice & Research Clinical Gastroenterology
language:en
Short-container-title:Best Practice & Research Clinical Gastroenterology

Author:

Katz Philip O.,Tutuian Radu

Publisher

Elsevier BV

Subject

Gastroenterology

Reference50 articles.

1. Prevalence and clinical spectrum of gastroesophageal reflux: a population based study in Olmstead county, Minnesota;Locke;Gastroenterology,1997

2. Relationship between upper gastrointestinal symptoms and lifestyle, psychosocial factors and comorbidity in general population: results from the Domestic/International Gastroenterology Surveillance Study (DIGEST);Stanghellini;Scandinavian Journal of Gastroenterology,1999

3. Extraesophageal gastroesophageal reflux disease. Presentations and approach to treatment;Fennerty;Gastroenterology Clinics of North America,1999

4. Appropriate acid suppression for the management of gastro-oesophageal reflux disease;Bell;Digestion,1992

5. Combined gastric and oesophageal pH-metry in patients with reflux disease, resistant to omeprazole;Klinkenberg-Knol;Alimentary Pharmacology and Therapeutics,1990

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antioxidant and Anti-Glycation Potential of H2 Receptor Antagonists—In Vitro Studies and a Systematic Literature Review;Pharmaceuticals;2023-09-08

2. Issues and controversies in esophageal inlet patch;World Journal of Gastroenterology;2019-08-14

3. Evaluation of rational nonsteroidal anti-inflammatory drugs and gastro-protective agents use; association rule data mining using outpatient prescription patterns;BMC Medical Informatics and Decision Making;2017-07-04

4. Pharmacokinetics, absorption, and excretion of radiolabeled revexepride: a Phase I clinical trial using a microtracer and accelerator mass spectrometry-based approach;Drug Design, Development and Therapy;2016-09

5. Proton pump inhibitors in GORDAn overview of their pharmacology, efficacy and safety;Pharmacological Research;2009-03